Skip to main content
Premium Trial:

Request an Annual Quote

Polyplus Raises $1.8M Through Convertible Bond Issuance

Premium

Polyplus Transfection said this week that it has raised €1.2 million ($1.8 million) through the issuance of convertible bonds to existing shareholders.

The company said the funds will primarily be used to support its RNAplus program, which is focused on developing RNAi oligos that do not require delivery reagents.

“We are delighted that all our existing shareholders have renewed their confidence in the company and its technologies,” Polyplus Chairman Gabriel Festoc said in a statement. "Thanks to this funding, we shall be able to reach a new stage in the development of Polyplus, after almost doubling our consolidated revenues to €2.6 million in 2009, and in particular to strengthen our research team for supporting our growth and investing in our key RNAplus program.”

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.